Abstract
Glutamatergic neurotransmission plays a critical role in addictive behaviors, and recent evidence indicates that genetic or pharmacological inactivation of the type 5 metabotropic glutamate receptor (mGluR5) reduces the self-administration of cocaine, nicotine, and alcohol. Because mGluR5 is coupled to activation of protein kinase C (PKC), and targeted deletion of the epsilon isoform (PKCϵ) in mice reduces ethanol self-administration, we investigated whether there is a functional link between mGluR5 and PKCϵ. Here, we show that acute administration of the mGluR5 agonist (R,S)-2-chloro-5-hydroxyphenylglycine to mice increases phosphorylation of PKCϵ in its activation loop (T566) as well as in its C-terminal region (S729). Increases in phospho-PKCϵ are dependent not only on mGluR5 stimulation but also on phosphatidylinositol-3 kinase (PI3K). In addition, the selective mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) reduced basal levels of phosphorylation of PKCϵ at S729. We also show that MPEP dose dependently reduced ethanol consumption in wild-type but not in PKCϵ-null mice, suggesting that PKCϵ is an important signaling target for modulation of ethanol consumption by mGluR5 antagonists. Radioligand binding experiments using [3H]MPEP revealed that these genotypic differences in response to MPEP were not a result of altered mGluR5 levels or binding in PKCϵ-null mice. Our data indicate that mGluR5 is coupled to PKCϵ via a PI3K-dependent pathway and that PKCϵ is required for the ability of the mGluR5 antagonist MPEP to reduce ethanol consumption.
- Received May 28, 2004.
- Accepted November 5, 2004.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|